
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Episode 263 Mark Domyahn, Partner at JD Lymon Group Strategic Reimbursement Planning for Medtech Innovators
In this episode, Mark Domayhn, Partner at JD Lymon Group, joins Duane Mancini to unpack what medtech innovators often miss most: reimbursement isn’t a box to check after FDA—it’s the commercial foundation that determines...